{
 "topic": "Phenylketonuria",
 "slug": "phenylketonuria",
 "category_id": 15597,
 "summary": "Why early detection and dietary treatment of PKU prevent irreversible brain damage, the biochemistry behind its characteristic odor and appearance, and lifelong dietary management including maternal PKU risk.",
 "written_by": "claude-sonnet",
 "references": [
  {
   "title": "2021_Fleisher_&_Ludwig's_Textbook_of_Pediatric_Emergency_Medicine.epub",
   "author": null,
   "pages": []
  },
  {
   "title": "Cover",
   "author": "Vitalsource Download",
   "pages": [
    1956,
    1960,
    1968
   ]
  },
  {
   "title": "Zitelli and Davis' Atlas of Pediatric Physical Diagnosis: Expert Consult - Online",
   "author": null,
   "pages": [
    56
   ]
  },
  {
   "title": "Pediatric Board Study Guide",
   "author": null,
   "pages": [
    163,
    165
   ]
  },
  {
   "title": "CURRENT Diagnosis and Treatment Pediatrics, Twenty-Fourth Edition",
   "author": "Hay, William W., Levin, Myron J., Deterding, Robin R., Abzug, Mark J.",
   "pages": [
    1108
   ]
  },
  {
   "title": "Pediatric Environmental Health",
   "author": "American Academy of Pediatrics Council on Environmental Health,Ruth A. Etzel,Sophie J. Balk",
   "pages": [
    53
   ]
  },
  {
   "title": "MedStudy Pediatrics Core 11th Edition 2024-2025",
   "author": null,
   "pages": [
    989
   ]
  },
  {
   "title": "AAP Developmental and Behavioral Pediatrics",
   "author": "AAP Section on Developmental and Behavioral Pediatrics,Robert G. Voigt,Michelle M. Macias ,Scott M. Myers ,Carl D Tapia",
   "pages": [
    684
   ]
  },
  {
   "title": "Netters Pediatrics (Florin \u0422., Ludwig St.)",
   "author": null,
   "pages": [
    798
   ]
  }
 ],
 "short": [
  {
   "title": "In short",
   "content": "- Classic PKU is caused by deficient phenylalanine hydroxylase (the enzyme converting phenylalanine to tyrosine); rarer variants come from deficiency of the cofactor tetrahydrobiopterin or defects in biopterin synthesis (these need additional treatment with neurotransmitter precursors, not diet alone).\n- Autosomal recessive; incidence in Caucasians is about 1 in 10,000\u201315,000 live births; the PAH gene maps to chromosome 12q24.1.\n- Classic PKU: phenylalanine persistently above 20 mg/dL, with normal or low tyrosine and characteristic urinary derivatives. Persistent hyperphenylalaninemia variants: phenylalanine 4\u201310 mg/dL.\n- Buildup of phenylacetic acid (from minor phenylalanine metabolic pathways) in sweat and urine produces the classic musty/mousy/wolflike/barny odor.\n- Infants appear normal at birth; more than 50% develop early symptoms \u2014 vomiting, irritability, eczematous rash, and the characteristic odor. Brain damage from elevated phenylalanine becomes irreversible by around 8 weeks of age, making early detection critical.\n- Untreated PKU causes: white-blond hair, blue eyes, fair complexion (relative to unaffected family members), eczema, microcephaly, hypertonicity, seizures, abnormal EEG, hyperactivity, and progressive/severe intellectual disability (IQ <30 in untreated cases).\n- Newborn screening detects nearly 100% of cases. Screening in the US may occur after 24 hours of life; elsewhere, testing after at least 48 hours is more typical; a second test is required if the first was done before 24 hours, and should be completed by the second week of life. First screening method (1963) was the bacterial-inhibition Guthrie test; modern screening uses tandem mass spectrometry where available.\n- Diagnosis confirmed by elevated plasma phenylalanine with an elevated phenylalanine:tyrosine ratio in a child on a normal diet; must be differentiated from other hyperphenylalaninemia causes by checking urine pterins and blood dihydropteridine reductase activity. Molecular testing enables carrier detection and prenatal diagnosis.\n- Treatment: lifelong phenylalanine-restricted diet (just enough natural protein from fruits/vegetables/limited starches to meet essential phenylalanine needs), supplemented with a phenylalanine-free medical formula containing tyrosine and other amino acids, started as soon as possible after birth; breastfeeding can continue under specialty clinic monitoring since breast milk has a lower phenylalanine content than many formulas, but must be carefully balanced against the medical formula. Aspartame (an artificial sweetener that is a phenylalanine source) must be avoided.\n- Outcomes: infants with phenylalanine control achieved by 3\u20134 weeks of age and maintained with good average control have good neuropsychological outcomes, though minor deficits can persist, especially with poor dietary compliance; well-treated patients may have mild tremor but are otherwise normal on exam. Maternal PKU (unrestricted diet during pregnancy in an affected mother) remains a persistent problem, risking fetal harm regardless of the fetus's own genotype."
  }
 ],
 "long": [
  {
   "title": "Definition",
   "content": "Phenylketonuria (PKU) is the classic and best-known disorder of amino acid metabolism, resulting from deficient activity of phenylalanine hydroxylase (PAH), the enzyme that converts phenylalanine to tyrosine. In classic PKU there is little or no PAH activity; less severe hyperphenylalaninemia variants retain significant residual enzyme activity. Rare variant forms result instead from deficiency of the cofactor tetrahydrobiopterin (BH4) or from defects in biopterin synthesis, and these require additional treatment with neurotransmitter precursors beyond dietary phenylalanine restriction alone. Classic PKU is defined by persistently elevated phenylalanine above 20 mg/dL with normal or low tyrosine and characteristic urinary derivatives, while variants with persistent hyperphenylalaninemia show phenylalanine in the 4\u201310 mg/dL range. PKU holds a distinct place in the history of inherited metabolic disease as the first genetic disorder shown to be treatable exclusively through dietary manipulation and preventable entirely through universal newborn screening with presymptomatic dietary intervention."
  },
  {
   "title": "Epidemiology",
   "content": "PKU is an autosomal recessive disorder, with an incidence in Caucasian populations of approximately 1 in 10,000 to 1 in 15,000 live births. Nearly all cases result from mutations in the gene encoding phenylalanine hydroxylase, mapped to human chromosome 12q24.1. Newborn screening, implemented in most developed countries since the late 1960s, detects nearly 100% of cases. The condition illustrates a clear gene-environment interaction: disease develops only when both the genetic predisposition (a PAH mutation) and environmental exposure (dietary phenylalanine, which is nearly universal in a normal diet) are present together."
  },
  {
   "title": "Pathophysiology",
   "content": "With deficient phenylalanine hydroxylase activity, phenylalanine accumulates and cannot be efficiently converted to tyrosine, forcing use of minor metabolic pathways that produce phenylacetic acid; this compound builds up in sweat and urine and is responsible for the characteristic odor described as musty, mousy, horsey, wolflike, barny, or like stale sweaty locker-room towels. Elevated phenylalanine is directly toxic to the central nervous system, killing brain cells and causing loss of developmental milestones if untreated; this neurotoxic damage becomes irreversible by around 8 weeks of age, which is the biological basis for the urgency of newborn screening and early dietary intervention. Clinical severity is determined less by the specific genetic variant and more by the quality and timing of metabolic (dietary) treatment."
  },
  {
   "title": "Clinical features",
   "content": "Infants with PKU appear entirely normal at birth, but early symptoms develop in more than half of affected infants, including vomiting, irritability, an eczematous rash, and the characteristic musty/mousy/wolflike odor from phenylacetic acid. Because tyrosine is a precursor for melanin, untreated patients typically have notably fairer hair, skin, and eye color than their unaffected relatives \u2014 classically described as white-blond hair, blue eyes, and fair complexion. If untreated, the disease progresses to microcephaly, hypertonicity, seizures (with abnormal EEG), hyperactivity, and severe, progressive intellectual disability, with IQ below 30 in untreated cases. Well-treated, diet-adherent patients generally have normal cognitive outcomes and a normal physical exam aside from a possible mild tremor, though some patients \u2014 particularly those with poor dietary compliance \u2014 experience mild-to-moderate residual deficits."
  },
  {
   "title": "Diagnostics",
   "content": "Diagnosis is based on demonstrating an elevated plasma phenylalanine concentration together with an elevated phenylalanine-to-tyrosine ratio in a child on a normal diet; this must occur during the neonatal period to allow timely treatment. PKU must be differentiated from other causes of hyperphenylalaninemia by examining urinary pterins and measuring dihydropteridine reductase activity in blood, since the biopterin-deficient variants require different (additional) treatment. Newborn screening, using tandem mass spectrometry where available (historically the bacterial-inhibition Guthrie test, later fluorimetry and colorimetry), is performed in the first few days of life; in the United States, screening may occur after 24 hours, while other countries more typically test after at least 48 hours. A second screening test is required if the first was performed before 24 hours of age, and should be completed by the second week of life, since outcome is best when treatment begins within the first month of life. Molecular (genetic) testing enables determination of carrier status and prenatal diagnosis of PKU or biopterin defects."
  },
  {
   "title": "Treatment",
   "content": "Treatment is a lifelong diet restricted in phenylalanine, providing just enough natural protein from fruits, vegetables, and limited starches to meet the essential phenylalanine requirement for growth and maintenance, supplemented with a phenylalanine-free medical formula containing tyrosine and other essential amino acids and nutrients, along with specially formulated low-phenylalanine foods. The medical formula should be started as soon as possible after birth. Breastfeeding can continue under close monitoring by a PKU specialty clinic, balanced against the phenylalanine-free formula, since breast milk still contains phenylalanine. The diet requires careful, ongoing monitoring by a nutritionist experienced in PKU management together with a metabolic disease clinic. Aspartame, an artificial sweetener that is itself a source of phenylalanine, must be avoided entirely. With phenylalanine levels controlled by 3\u20134 weeks of age and maintained under good average control thereafter, most patients achieve good neuropsychological outcomes, though minor deficits can persist, particularly with poor dietary adherence. Maternal PKU is a distinct, ongoing concern: an affected mother who does not maintain strict phenylalanine restriction during pregnancy exposes the fetus to damaging phenylalanine levels regardless of the fetus's own PKU genotype."
  }
 ],
 "clinical": [
  {
   "title": "Management at the bedside",
   "content": "Ensure every newborn receives screening in the first few days of life, and specifically repeat testing by the second week of life for any infant screened before 24 hours of age, since delayed detection risks irreversible neurologic damage that begins to occur by about 8 weeks of age. If an infant presents with vomiting, irritability, an eczematous rash, and a musty/mousy odor \u2014 particularly if fairer in complexion than unaffected relatives \u2014 consider PKU even if newborn screening was reportedly normal or is pending, and pursue plasma phenylalanine and phenylalanine:tyrosine ratio testing; a urine ferric chloride test can be a rapid adjunct in the emergency setting when the characteristic odor prompts suspicion.\n\nOnce PKU is confirmed, initiate a phenylalanine-restricted diet with a phenylalanine-free medical formula as soon as possible, and refer to a metabolic disease clinic and a nutritionist experienced in PKU for ongoing, careful dietary monitoring \u2014 the treatment is lifelong, not just an infant/childhood intervention. Support continued breastfeeding if the family wishes, but only with close specialty clinic oversight to balance breast milk's phenylalanine content against formula and dietary needs. Counsel families explicitly that aspartame-containing products must be avoided completely, since this common sweetener is a hidden phenylalanine source.\n\nDifferentiate classic PKU from the rarer biopterin-related variants by checking urinary pterins and blood dihydropteridine reductase activity, since these variants need additional treatment with neurotransmitter precursors beyond diet alone \u2014 missing this distinction means diet alone will not prevent neurologic damage in these patients. For any young woman with PKU approaching or during childbearing age, emphasize strict return to (or maintenance of) phenylalanine restriction before and throughout pregnancy, since maternal PKU can cause fetal harm irrespective of the fetus's own genetic status. Monitor treated children with phenylalanine level testing coordinated by the metabolic clinic to confirm control is achieved early (ideally by 3\u20134 weeks of age) and sustained over time, since both the timing and the consistency of control drive long-term cognitive outcome."
  }
 ]
}